Green Cross to market medicine for irritable bowel syndrome, Algiron

Published: 2008-06-20 06:54:00
Updated: 2008-06-20 06:54:00
Green Cross Corporation entered into an exclusive agreement with Boehringer Ingelheim Korea over Algiron (cimetropium bromide).

Under the agreement, GCC will market the new antimuscarinic compound in Korea on an exclusive basis.

Studies have shown that Algiron is effective in relieving pain...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.